Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
Short Course: November 13
Conference: November 14-15
Need approval in order to attend?
Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.Preconference Short Course
Introduction to Real World Data for Data Geeks
Check out our 2019 Program!
Who should attend?
Professionals involved in:
- Real World Evidence
- Epidemiology
- Policy
- Regulatory Science
- Technology Development
- Data Analytics
- Clinical Research
Learning objectives
- Discuss how RWE is being used today to inform biopharmaceutic development across product lifecycle
- Describe the recent FDA strategic framework for RWD in regulatory decisions
- Evaluate the future applications of RWE in drug development
- Appraise how mobile technologies, AI, machine learning, and other technologies are being used to generate RWE
- Evaluate how patient reported outcomes, EHR, and other patient data is expanding the resources for RWE
- Discuss “lessons learned” from current uses of RWE, and how these can be applied for other future applications of RWE
Program Committee
-
Robert Suruki • RWE Strategy Lead, Immunology
UCB Pharma, Inc., Belgium -
Bart Barefoot • Director, VEO, Real World Evidence Policy and Advocacy
GlaxoSmithKline, United Kingdom -
Brian D. Bradbury, PhD, MA • Vice President, Center for Observational Research
Amgen, United States -
Paul M. Coplan, DrSc, MBA, MSc, FISPE • Vice President, Medical Device Epidemiology & Real-World Data Analytics
Johnson & Johnson, United States -
Jacqueline A. Corrigan-Curay, JD, MD • Director, Office of Medical Policy, CDER
FDA, United States -
Nancy A. Dreyer, PhD, MPH, FISPE • Chief Scientific Officer and Senior Vice President
IQVIA, United States -
Marni Hall, PhD, MPH • Vice President, Clinical Evidence
IQVIA, United States -
James Harnett, PharmD, MS • Executive Director, Health Economics & Outcomes Research
Regeneron Pharmaceuticals, Inc., United States -
Debra Schaumberg, DrSc, MPH • Vice President, Epidemiology & Head Strategic and Scientific Affairs
Evidera|Ppd, United States -
Mark Stewart, PhD • Vice President, Science Policy
Friends of Cancer Research, United States
Contact us
Registration Questions?
Preconference Short Course
Introduction to Real World Data for Data Geeks
Check out our 2019 Program!